{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:24:06Z","timestamp":1787819046205,"version":"build-2784847793"},"reference-count":30,"publisher":"BMJ","issue":"19","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2014,5,27]]},"published-print":{"date-parts":[[2014,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We conducted a randomised, double blind, placebo controlled trial to assess the efficacy and safety of cilostazol, a selective inhibitor of phosphodiesterase 3, in patients with vasospastic angina (VSA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cilostazol has been shown to induce vascular dilatation, but its efficacy in patients with VSA is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between October 2011 and July 2012, 50 patients with confirmed VSA who had \u22651 angina episodes\/week despite amlodipine therapy (5\u2005mg\/day) were randomly assigned to receive either cilostazol (up to 200\u2005mg\/day) or placebo for 4\u2005weeks. All patients were given diaries to record the frequency and severity of chest pain (0\u201310 grading). The primary endpoint was the relative reduction of the weekly incidence of chest pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline characteristics were similar between the two groups. Among 49 evaluable patients (25 in the cilostazol group, 24 in the placebo group), the primary endpoint was significantly greater in the cilostazol group compared with the placebo group (\u221266.5\u00b188.6% vs \u221217.6\u00b1140.1%, respectively, p=0.009). The secondary endpoints, including a change in the frequency of chest pain (\u22123.7\u00b10.5 vs \u22121.9\u00b10.6, respectively, p=0.029), a change in the chest pain severity scale (\u22122.8\u00b10.4 vs \u22121.1\u00b10.4, respectively, p=0.003), and the proportion of chest pain-free patients (76.0% vs 33.3%, respectively, p=0.003) also significantly favoured cilostazol. Headache was the most common adverse event in both groups (40.0% vs 20.8%, respectively, p=0.217).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cilostazol is an effective therapy for patients with VSA uncontrolled by conventional amlodipine therapy, and has no serious side effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NCT01444885.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2014-305986","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:18:03Z","timestamp":1402964283000},"page":"1531-1536","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":51,"title":["A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina"],"prefix":"10.1136","volume":"100","clinical-trial-number":[{"clinical-trial-number":"nct01444885","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Eun-Seok","family":"Shin","sequence":"first","affiliation":[{"name":"Division of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hwan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Internal Medicine, School of Medicine, Chungnam National University Hospital, Daejeon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yong","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, University of Ulsan College of Medicine, GangNeung Asan Hospital, Gangneung, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwhi","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine Gyeongsang National University Hospital and Gyeongsang National University School of Medicine, Jinju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joon","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moo Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Wook","family":"Nam","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Keimyung University, Dongsan Medical Center, Daegu, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jea","family":"Tahk","sequence":"additional","affiliation":[{"name":"Ajou University Hospital, Suwon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Su","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University, Yangsan Hospital, Yangsan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Jeong","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine Gyeongsang National University Hospital and Gyeongsang National University School of Medicine, Jinju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Whan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Kyoung","family":"Shin","sequence":"additional","affiliation":[{"name":"School of Korean Medicine, Pusan National University, Yangsan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June-Hong","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University, Yangsan Hospital, Yangsan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,6,16]]},"reference":[{"key":"2025100703210081000_100.19.1531.1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(89)90842-9"},{"key":"2025100703210081000_100.19.1531.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.63.4.844"},{"key":"2025100703210081000_100.19.1531.3","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-10-0292"},{"key":"2025100703210081000_100.19.1531.4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90606-2"},{"key":"2025100703210081000_100.19.1531.5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90271-2"},{"key":"2025100703210081000_100.19.1531.6","first-page":"1144","article-title":"Effect of cilostazol on platelet aggregation and experimental thrombosis","volume":"35","author":"Kimura","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"2025100703210081000_100.19.1531.7","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.7.678"},{"key":"2025100703210081000_100.19.1531.8","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.1.21"},{"key":"2025100703210081000_100.19.1531.9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701699"},{"key":"2025100703210081000_100.19.1531.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2012.00312.x"},{"key":"2025100703210081000_100.19.1531.11","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-10-74-0802"},{"key":"2025100703210081000_100.19.1531.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.37.4.378"},{"key":"2025100703210081000_100.19.1531.13","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90310-W"},{"key":"2025100703210081000_100.19.1531.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00259-4"},{"key":"2025100703210081000_100.19.1531.15","doi-asserted-by":"publisher","DOI":"10.1159\/000089723"},{"key":"2025100703210081000_100.19.1531.16","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.164368"},{"key":"2025100703210081000_100.19.1531.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.01.022"},{"key":"2025100703210081000_100.19.1531.18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-9149(03)00458-2","article-title":"Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris","volume":"92","author":"Watanabe","year":"2003","journal-title":"Am J Cardiol"},{"key":"2025100703210081000_100.19.1531.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044476"},{"key":"2025100703210081000_100.19.1531.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6921.81"},{"key":"2025100703210081000_100.19.1531.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2003.10.022"},{"key":"2025100703210081000_100.19.1531.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.05.067"},{"key":"2025100703210081000_100.19.1531.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.892414"},{"key":"2025100703210081000_100.19.1531.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70198-8"},{"key":"2025100703210081000_100.19.1531.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.01.349"},{"key":"2025100703210081000_100.19.1531.26","doi-asserted-by":"publisher","DOI":"10.1007\/s12928-012-0105-4"},{"key":"2025100703210081000_100.19.1531.27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.822791"},{"key":"2025100703210081000_100.19.1531.28","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200412000-00004"},{"key":"2025100703210081000_100.19.1531.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04177.x"},{"key":"2025100703210081000_100.19.1531.30","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314916"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2014-305986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T10:21:11Z","timestamp":1759832471000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2014-305986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,16]]},"references-count":30,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2014,9,9]]},"published-print":{"date-parts":[[2014,10,1]]}},"alternative-id":["10.1136\/heartjnl-2014-305986"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2014-305986","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,16]]}}}